2. Modes of bacterial contaminationin
stored blood:
- Bacterial Contamination: Etiology
Blood components may be contaminated by:
1. Unrecognized bacteremia in the donor.
For example: Yersinia enterocolitica
2. Skin organisms fromthe donor.
•Difficult to totally decontaminate surfaceof human skin.
•Small coreof skin may enter phlebotomy needle at time of donation (~65% of
donations)
•Bacterial present in deep layers of skin.
For example: Staphylococcusepidermidis
3. Contamination fromthe environmentor handling of the product
•Leaky seals damaged tubing etc.
For example: Serratia marcescens
BacterialContamination— commonly
implicatedbacteria:
The bacterial contamination commonly
implicated bacteria contains both Gram +veand Gram –vebacteria which are
as follows:
- Gram-negative:
•Escherichia coli
•Serratia marcescens
•Klebsiella pneumoniae
•Pseudomonasspecies
•Yersinia enterocolitica
4. Component Bacterial
Contamination
Symptomatic
Septic
Reactions
Fatal
Bacterial
Sepsis
Platelet pool 1 in 1,000 1 in 10,000 1 in 60,000
RBC (1 unit) 1 in 50,000 1 in 250,000 1 in 500,000
1- Most frequentinfectious risk associated with transfusion.
2- Accounted for ~11% of deaths due to blood components reported to US
FDA 2007-2011.
3- Occurs mostfrequently with platelets.
-Stored at 20-24°C
-Excellent growth medium for bacteria.
Side Effects on contaminatedblood
transfusion:
- Immediate Adverse Effects Associated with
Transfusion:
•Acute hemolytic transfusion reaction
•Febrile non-hemolytic transfusion reaction
•Allergic reactions
•Urticarial
•Anaphylactic
•Transfusion-associated circulatory overload (TACO)
•Transfusion-associated dyspnea (TAD)
•Transfusion-related acutelung injury (TRALI)
•Septic transfusion reaction (bacterial contamination)
6. Classification of reaction by predominant
symptom/sign:
We will focus on 3 common symptoms and signs:
1. Fever
2. Dyspnea
3. Rash and other allergic reaction
According to immunology:
Immune:
•Passivetransfer of donor alloantibodies in plasma of transfused product
•Anti-HLA (Class I)
•Anti-HLA (Class II)
•Human neutrophil antigens (HNA)
•Antibody binding to circulating WBC (and perhaps also pulmonary endothelium)
causes cellular activation
Non-immune:
•TRALI is also caused by the infusion of “biologic responsemodifiers” within the
blood component
•Cytokines (IL-6, IL-8, IL-1, TNF-
•Lipids with neutrophil-priming activity
•CD40 ligand
•These substances accumulate in cellular blood products with prolonged storage
Silliman
Serious Reaction:
•Hypotension/shock
•Shortness of breath
•Hypoxemia
•Hemoglobinuria
•Nausea and vomiting
•Bleeding fromIV sites
•Back pain
•Chest pain
7. Transfusion Reaction with fever:
1-Febrilenon-hemolytic transfusion reaction
2-Bacterial contamination
3-Acutehemolytic transfusion reaction
4-Usually temp greater than 39°C.
Transfusion reaction with rash:
•Mild allergic reactions
•Serious allergic reactions
•Anaphylaxis
•Anaphylactoid reactions
•Reactions unrelated to transfusion
Transfusion reaction with dyspnea:
•European Haemovigilience Network (EHN) introduced term to allow for
classification of respiratory distress temporally associated with transfusion which
could not be assigned to known pulmonary reactions
•“Characterized by respiratory distress within 24 hours of transfusion thatdoes
not meet the criteria of TRALI, TACO or allergic reaction should not be explained
by patient’s underlying condition”